Plain-English translation of NCT06152107 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing InterVapor, a device that uses heat to shrink damaged areas of the lung in people with severe emphysema. The study compares two approaches: treating very small, precise areas of damage versus treating larger areas. Researchers want to see which approach helps patients breathe better and is safer.
Severe emphysema causes progressive lung damage and breathing problems that limit daily life. Current treatment options are limited, and doctors need better ways to help patients breathe easier and improve their quality of life.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to receive treatment with the InterVapor device in either smaller, more targeted areas or in larger areas of your damaged lung. The treatment is performed during a bronchoscopy procedure (a thin tube passed through your airway to reach the lungs). You would also receive standard emphysema medications and care. You would have follow-up visits and breathing tests to track how you're doing after treatment.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China